Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination & Remuneration Committee and the Board of Directors. As the first CEO of the integrated Biocon, he will lead the combined platform spanning biosimilars and generics, strengthening the Company’s ability to operate at scale and compete effectively in global markets.
